Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 54.33-44.2617.0052.4650.10

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 54.33 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,707.7 Cr 2.9% 5.2% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.9%

5.2%

26.7%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses